Raymond James & Associates’s Prospect Capital PSEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-21,500
Closed -$1K 4101
2022
Q2
$1K Buy
+21,500
New +$165K ﹤0.01% 4013
2021
Q4
Sell
-50,100
Closed -$3K 4253
2021
Q3
$3K Buy
50,100
+10,400
+26% +$83.8K ﹤0.01% 4089
2021
Q2
$2K Sell
39,700
-36,300
-48% -$303K ﹤0.01% 4073
2021
Q1
$8K Buy
+76,000
New +$525K ﹤0.01% 3963

Other funds holding PSEC

Raymond James & Associates's PSEC Position: Q3 2024 in Review

Raymond James & Associates increased its Prospect Capital (PSEC) stake by 11% in Q3 2024, buying an estimated $446K and bringing the position to 846,244 shares worth $4.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1721.

Raymond James & Associates first reported a position in PSEC in Q2 2013 and has held it in 46 quarters since. 226 funds tracked by Wall St. Rank hold PSEC as of Q3 2024.

  • Raymond James & Associates held 846,244 shares of Prospect Capital worth $4.53M as of Q3 2024.
  • Raymond James & Associates bought 84,050 Prospect Capital shares in Q3 2024, an estimated $446K.
  • Prospect Capital made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1721 holding.
  • Raymond James & Associates first reported a position in Prospect Capital in Q2 2013 and has held it in 46 quarters since.
  • 226 funds tracked by Wall St. Rank held Prospect Capital as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.